Summit Therapeutics Inc. Quarterly Goodwill in USD from Q4 2016 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.
Summary
Summit Therapeutics Inc. quarterly Goodwill history and growth rate from Q4 2016 to Q3 2024.
  • Summit Therapeutics Inc. Goodwill for the quarter ending September 30, 2024 was $1.99M, a 9.76% increase year-over-year.
Goodwill, Quarterly (USD)
Goodwill, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $1.99M +$177K +9.76% Sep 30, 2024 10-Q 2024-10-30
Q2 2024 $1.88M -$3K -0.16% Jun 30, 2024 10-Q 2024-08-06
Q1 2024 $1.88M +$36K +1.96% Mar 31, 2024 10-Q 2024-05-01
Q4 2023 $1.89M +$95K +5.28% Dec 31, 2023 10-Q 2024-10-30
Q3 2023 $1.81M +$159K +9.61% Sep 30, 2023 10-Q 2023-11-07
Q2 2023 $1.88M +$77K +4.26% Jun 30, 2023 10-Q 2023-08-09
Q1 2023 $1.84M -$114K -5.84% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 $1.8M -$211K -10.5% Dec 31, 2022 10-K 2024-02-20
Q3 2022 $1.66M -$346K -17.3% Sep 30, 2022 10-Q 2022-11-09
Q2 2022 $1.81M -$251K -12.2% Jun 30, 2022 10-Q 2022-08-11
Q1 2022 $1.95M -$94K -4.59% Mar 31, 2022 10-Q 2022-05-11
Q4 2021 $2.01M -$21K -1.03% Dec 31, 2021 10-K 2023-03-09
Q3 2021 $2M -$334K -14.3% Sep 30, 2021 10-Q 2021-11-15
Q2 2021 $2.06M -$179K -8.01% Jun 30, 2021 10-Q 2021-08-12
Q1 2021 $2.05M Mar 31, 2021 10-Q 2021-05-17
Q4 2020 $2.03M +$69K +3.52% Dec 31, 2020 10-K/A 2022-12-21
Q3 2020 $2.34M Sep 30, 2020 10-Q 2020-11-16
Q2 2020 $2.24M Jun 30, 2020 8-K 2020-09-29
Q4 2019 $1.96M +$10K +0.51% Dec 31, 2019 10-K 2021-03-31
Q4 2018 $1.95M -$1.56M -44.5% Jan 31, 2019 10-K 2021-03-31
Q4 2017 $3.51M +$2.68M +320% Jan 31, 2018 8-K 2020-09-29
Q4 2016 $836K Jan 31, 2017 8-K 2020-09-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.